The spatial genomics & transcriptomics market is prognosticated to bring profitable growth during the assessment period of 2019-2027.
The spatial genomics & transcriptomics market is prognosticated to bring profitable growth during the assessment period of 2019-2027. The growing incidence of various genetic disorders such as neurological disorders, cancer, and others will bring tremendous growth prospects for the spatial genomics & transcriptomics market. Technological advancements in the genetic engineering space will also play a vital role in the growth of the spatial genomics & transcriptomics market.
- An increase in the collaborations between research institutes and numerous countries will have a positive impact on the growth of the spatial genomics & transcriptomics market. The players are focusing on these activities for deriving new formulations and upgrading their processes. These upgrades help in providing enhanced convenience and benefit to the consumers, eventually increasing the growth rate of the spatial genomics & transcriptomics market.
- Mergers, acquisitions, partnerships, and joint ventures are crucial for the spatial genomics & transcriptomics market growth. The players indulge in these collaborations for expanding their foothold across the spatial genomics & transcriptomics market, ultimately sowing the seeds of growth. The players also concentrate on expanding their service offerings. This factor will have a profound impact on the growth of the spatial genomics & transcriptomics market.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=69182
Global Spatial Genomics & Transcriptomics Market: Introduction
Spatial genomics & transcriptomics enables researchers to not only see what is in a cell but how cells are organized in relation to one another, offering invaluable insights into understanding a disease by using the data that was earlier beyond the reach of modern methods. Spatial genomics & transcriptomics incorporates the exploration and assortment of transcriptomes. It has diverse applications, primarily in molecular genetics. The global spatial genomics & transcriptomics market is witnessing a lot of instances of new product launches. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suitable for use in low-abundance transcript applications, as it offers an extremely sensitive whole transcriptomics solution. This innovation embodies three powerful technologies for performing high-sensitivity ribonucleic acid (RNA) analysis: single-primer isothermal amplification (SPIA), DimerFree, and AnyDeplete.
Request for Analysis of COVID-19 Impact on Spatial Genomics & Transcriptomics Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=69182
Global Spatial Genomics & Transcriptomics Market: Competition Landscape
Key players operating in the global spatial genomics & transcriptomics market are focusing on mergers and acquisitions. For instance, in December 2018, 10X Genomics acquired Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics. Spatial Transcriptomics offers a technology designed to allow RNA sequencing to perform in the 2D technology. In August 2018, 10X Genomics acquired Epinomics, a pioneer in the growing space of epigenetics. The acquisition would provide 10X Genomics with the ATAC-seq technology and fundamental IP to accelerate discoveries and conduct further research in epigenomics.
Pre book Spatial Genomics & Transcriptomics Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=69182<ype=S
10X Genomics
Founded in 2012, 10X Genomics is headquartered in California, the U.S. The company develops integrated systems and solutions for genome sequencing, exome sequencing, and single-cell transcriptomics. 10X Genomics, Inc. was formerly known as 10X Technologies, Inc. and it changed its name to 10X Genomics, Inc. in March 2015. The company offers chromium single-cell gene expression solutions, chromium single-cell immune profiling solutions, chromium single-cell CNV solutions, chromium single-cell ATAC solutions, chromium genome solutions, chromium exome solutions, and chromium de novo assembly solutions.
Illumina, Inc.
Established in 2000, Illumina, Inc. is headquartered in California, the U.S. The company is a global life science company engaged in the development and commercialization of genetic analysis solutions covering the areas such as sequencing, genotyping, and expression. The company operates its business through two major segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of Illumina, Inc.’s core operations. Core Illumina’s products and services serve customers in research, clinical, and applied sectors and enable the adoption of a wide range of genomic solutions. The company provides whole-genome sequencing, genotyping, NIPT, and support services. The company’s technology platforms support the scale of experimentation required for population-scale studies, genome-wide discovery, target selection, and validation studies.
Top of Form
Dovetail Genomics LLC
Founded in 2013, Dovetail Genomics LLC is headquartered in California, the U.S. The company’s business line includes providing commercial, physical and biological research and development services. The company is involved in de novo assembly, structural variation, microbiome analysis, cancer research, phasing analysis, and comprehensive view of genomes. In 2018, the company introduced its first commercial service for analysis of human genomes.
Read More Information:
https://www.transparencymarketresearch.com/spatial-genomics-transcriptomics-market.html
Global Spatial Genomics & Transcriptomics Market – Dynamics
Drug discovery and disease identification a key driver
Increasing awareness about disease management and drug discovery drives the global spatial genomics & transcriptomics market. Disease management and drug discovery are the most rapidly expanding application segments of the market. The rise in genome knowledge has led to increased research in several, rare, genetic and oncology diseases. Also, the increasing demand from diagnostics in neurology and immunology as well as other areas of biology has been significantly driving the market. Personalized medicine and companion diagnostics are significant add-on part responsible for growth of the global spatial genomics & transcriptomics market. According to a magazine called Labtimes, over 700,000 genetic tests are performed in Europe every year and over 30 million people suffer from some form of a genetic disorder. Spatial genomics technology bridges microscopy and RNA sequencing to generate complete transcriptome data from a single intact tissue sample and utilizes standard instrumentation for sequencing already present in most labs, allowing for barrier-free adoption.
Increased investments in genomics
With increasing investment in spatial genomics & transcriptomics along with expanding supporting growth from investors are expected to offer the greatest market attractiveness in terms of revenue. Certain countries do have challenging entry barriers in terms of political and legal framework clearance. However, with increasing awareness and adoption, the market penetration is expected to offset the entry barriers. Government funding and support and collaborative research with large pharmaceutical players are estimated to be significant drivers of this market in the near future. For instance, in January 2019, 10X Genomics received a combined funding of US$ 243 Mn, of which US$ 35 Mn was an extension of 10X Genomics Series-D financing.
Browse More Trending Reports by Transparency Market Research:
Contact lenses are extensively used in order to correct vision inaccuracies and compensate for vision problems such as presbyopia, hypermetropia/hyperopia, and astigmatism. These lenses are coated with scratch resistance materials, ultraviolet protection, and anti-refractive material to provide best therapeutic experience along with comfort to the user.As per the U.S. FDA, the contact lenses has been categorized into class II and class III medical devices on the basis of their usage. Regular use contact lenses are defined as class II medical devices by the U.S. FDA, as these contact lenses may pose threat to users, if used without correct advice of physician. Further, contact lenses used for an extended time period is categorized as class III medical devices. These lenses pose a higher degree of risk in terms of safety and health, if used without advice of physician.
The demand within the global corporate wellness market is growing on account of advancements in the domain of employee welfare. The corporate sector has come under the radar of scrutiny, and is being closely monitored for its employee welfare policies. The emergence of a new era within corporate wellness has improved the performance of the workers. The focus on providing optimal benefits to employees has created humongous opportunities for market growth and maturity. Large MNCs and corporate houses host several events and drills aimed at fostering corporate wellness. These events can cover a range of areas, spanning into healthcare, insurance, and other individual needs. Therefore, the value of the global corporate wellness market is expected to touch new heights in the times to follow.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453